Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

WeedMD appoints former Tilray Canada executive Beth Carreon as CFO

Carreon, whose appointment is effective May 3, succeeds Lincoln Greenidge

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) has tapped Beth Carreon, a seasoned financial executive with broad experience in corporate finance, mergers and acquisitions (M&A), banking, and consumer-packaged-goods (CPG), as its new CFO.

Carreon, whose appointment is effective May 3, succeeds Lincoln Greenidge, who will be stepping down on April 30, the company said.

Most recently, Carreon served as vice president of finance at Tilray Canada, where she successfully led and managed the company’s global treasury, shared services, and financial planning teams as well as M&A integration activities.

READ: WeedMD debuts its first live resin extract product under the Pedro's Sweet Sativa brand

WeedMD said she brings significant experience in both the cannabis and the CPG industries, having previously worked over 12 years at Nestlé Canada Inc in progressive finance leadership roles. Carreon began her career as an auditor and management consultant with tenures at major accounting firms including Ernst & Young, PricewaterhouseCoopers, and Deloitte.

“We are thrilled to welcome Beth to our team as we move into a period of aggressive commercial expansion and continue to optimize our operations for future sustainable revenue growth,” said George Scorsis, CEO and executive chair, of WeedMD. “Beth is a dynamic and inspiring leader with an excellent reputation for execution. Her extensive experience in securing tactical development opportunities, both internally and externally, brings considerable bench-strength to the team as we drive to meet our profitability goals going forward.”

Scorsis added: “I want to thank Lincoln for all his contributions during our pivotal, year-long integration period with Starseed Medicinal and we wish him all the best in his future pursuits.”

Carreon commented: “I’m excited to be joining the WeedMD family at this watershed moment as the company progresses to the next phase of its commercialization plans and growth strategy. I’ve long admired WeedMD’s culture, cultivation pedigree and innovative product portfolio and I look forward to leading its finance organization and contributing to its long-term success.”

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK